TIDMVLG

Venture Life Group PLC

31 January 2017

Venture Life Group plc

("Venture Life" or the "Group")

Investor Day presentation now available

Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the ageing population, announces that the presentations delivered on Thursday 26 January 2017, along with the recorded audio, are now available to view on the Group's website:

http://www.venture-life.com/node/328

For further information please contact:

 
 Venture Life Group PLC                            +44 (0) 1344 742870 
 Jerry Randall, Chief Executive 
  Officer 
 
 Panmure Gordon (UK) Limited (Nominated                +44 (0) 20 7886 
  Adviser and Joint Broker)                                       2500 
 Freddy Crossley/Peter Steel/Duncan 
  Monteith (Corporate Finance) 
 Tom Salvesen (Corporate Broking) 
 
 Turner Pope Investments (TPI) Ltd                     +44 (0) 20 3621 
  (Joint Broker)                                                  4120 
 James Pope/Ben Turner 
 
 Walbrook PR                                venturelife@walbrookpr.com 
                                               or +44 (0) 20 7933 8780 
 Paul McManus/Anna Dunphy                   +44 (0) 7980 541 893 / +44 
                                                      (0) 7876 741 001

About Venture Life (www.venture-life.com)

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group's product range and pipeline currently includes the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin.

The products, which typically are recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.

Through its Development & Manufacturing business, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAFMGFMVMRGNZM

(END) Dow Jones Newswires

January 31, 2017 11:39 ET (16:39 GMT)

Venture Life (LSE:VLG)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Venture Life Charts.
Venture Life (LSE:VLG)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Venture Life Charts.